首页> 外文OA文献 >Dynamics of Platelet Counts in Major Trauma: The Impact of Haemostatic Resuscitation and Effects of Platelet Transfusion—A Sub-Study of the Randomized Controlled RETIC Trial
【2h】

Dynamics of Platelet Counts in Major Trauma: The Impact of Haemostatic Resuscitation and Effects of Platelet Transfusion—A Sub-Study of the Randomized Controlled RETIC Trial

机译:主要创伤中血小板计数的动态:血压复苏的影响和血小板输血的影响 - 一种随机控制的审判的子研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although platelets play a central role in haemostasis, the dynamics of platelet counts during haemostatic resuscitation, the response to platelet transfusion, and effects on clinical outcome are poorly described for trauma patients. As a sub-study of the already published randomized controlled RETIC Study “Reversal of Trauma-induced Coagulopathy using First-line Coagulation Factor Concentrates or Fresh-Frozen Plasma” trial, we here analysed whether the type of first-line haemostatic resuscitation influences the frequency of platelet transfusion and determined the effects of platelet transfusion in coagulopathic patients with major trauma. Patients randomly received first-line plasma (FFP) or coagulation factor concentrates (CFC), mainly fibrinogen concentrate. In both groups, platelets were transfused to maintain platelet counts between 50 and 100 × 109 /L. Transfusion rates were significantly higher in the FFP (n = 44) vs. CFC (n = 50) group (FFP 47.7% vs. CFC 26%); p = 0.0335. Logistic regression analysis adjusted for the stratification variables injury severity score (ISS) and brain injury confirmed that first-line FFP therapy increases the odds for platelet transfusion (odds ratio (OR) 5.79 (1.89 to 20.62), p = 0.0036) and this effect was larger than a 16-point increase in ISS (OR 4.33 (2.17 to 9.74), p =0.0001). In conclusion, early fibrinogen supplementation exerted a platelet-saving effect while platelet transfusions did not substantially improve platelet count and might contribute to poor clinical outcome.
机译:虽然血小板在止血中发挥着核心作用,但血小板复苏期间的血小板计数的动态,对血小板输注的反应以及对创伤患者的临床结果的影响很差。作为已经发表的随机控制的次级研究“使用一线凝血因子浓缩物或新冷冻血浆的创伤诱发的凝血病变的逆转或新冷冻血浆”试验,我们在这里分析了一线血管报复活的类型是否影响了频率血小板输血并确定血小板输血在凝血疗法中血小板输注患者的主要创伤患者。患者随机接受一线血浆(FFP)或凝血因子浓缩物(CFC),主要是纤维蛋白原浓缩物。在这两组中,将血小板转移到维持50至100×109 / L之间的血小板计数。 FFP(n = 44)与CFC(n = 50)组(FFP 47.7%Vs.CFC 26%)显着较高(FFP 47.7%); P = 0.0335。对分层变量调整的逻辑回归分析损伤严重程度评分(ISS)和脑损伤证实,一线FFP疗法增加了血小板输血的几率(差距(或)5.79(1.89至20.62),p = 0.0036)和这种效果ISS(或4.33(2.17至9.74),P = 0.0001)大于16点增加。总之,早期纤维蛋白原补充施加了血小板效果,而血小板输血没有显着改善血小板计数,并且可能导致临床结果不良。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号